Search results
FDA approves Moderna’s mRNA RSV vaccine for older adults
CNN via Yahoo News· 5 hours agoThe US Food and Drug Administration has approved another vaccine that can help protect older people...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 2 hours agoModerna's vaccine was approved for the prevention of RSV-associated lower respiratory tract disease...
Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine
Benzinga via Yahoo Finance· 5 hours agoOn Friday, the FDA approved Moderna Inc’s (NASDAQ:MRNA) mRESVIA (mRNA-1345), an mRNA respiratory...
The FDA is weighing whether to approve MDMA for PTSD. Here's what that could look like for patients.
CBS News· 6 hours agoDetails of the FDA's proposal were published Friday in a set of documents released by the agency...
FDA staff questions safety of ecstasy for PTSD
Axios· 3 hours agoWhy it matters: The findings cast new doubts on what could become the first psychedelic-based treatment approved in the U.S. ahead of a June 4 meeting...
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
CNBC· 9 hours agoThe Food and Drug Administration on Friday approved Moderna's vaccine for respiratory syncytial...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 5 hours agoToday, the FDA approved mRESVIA (Respiratory Syncytial Virus Vaccine) for the prevention of lower respiratory tract disease (LRTD) caused by respiratory ...
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks via Yahoo Finance· 10 hours agoPer the FDA, the data submitted by Sanofi (SNY)/Regeneron (REGN) for Dupixent in COPD indication...
Moderna secures a second FDA vaccine approval as Spikevax sales plummet
Fast Company Magazine· 4 hours agoModerna announced on Friday that the U.S. Food and Drug Administration (FDA) has approved its...
JD Supra: FDA Makes Good on Its Promise to Regulate Laboratory-Developed Tests
JD Supra· 4 hours agoYesterday, the Food & Drug Administration (“FDA” or “the Agency”) issued a highly anticipated – and highly controversial – final rule, which rolls out a four-year, five-stage ...